MIRA
INFORM REPORT
|
Report Date : |
31.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
GLOBEGEN LABORATORIES LIMITED |
|
|
|
|
Formerly Known As : |
GLOBGEN LABORATORIES LIMITED |
|
|
|
|
Registered Office : |
1406 Coventry Road Yardley Birmingham B25 8AE |
|
|
|
|
Country : |
United Kingdom |
|
|
|
|
Date of Incorporation : |
17.04.2012 |
|
|
|
|
Com. Reg. No.: |
08033231 |
|
|
|
|
Legal Form : |
Private limited with Share Capital |
|
|
|
|
Line of Business : |
Distribution of Pharmaceutical Products |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
NB |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
-- |
NB |
New Business |
-- |
|
Status : |
New Company |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
United Kingdom |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
UNITED KINGDOM - ECONOMIC OVERVIEW
The UK, a leading trading power
and financial center, is the third largest economy in Europe after Germany and
France. Over the past two decades, the government has greatly reduced public
ownership and contained the growth of social welfare programs. Agriculture is
intensive, highly mechanized, and efficient by European standards, producing
about 60% of food needs with less than 2% of the labor force. The UK has large
coal, natural gas, and oil resources, but its oil and natural gas reserves are
declining and the UK became a net importer of energy in 2005. Services,
particularly banking, insurance, and business services, account by far for the
largest proportion of GDP while industry continues to decline in importance.
After emerging from recession in 1992, Britain's economy enjoyed the longest
period of expansion on record during which time growth outpaced most of Western
Europe. In 2008, however, the global financial crisis hit the economy
particularly hard, due to the importance of its financial sector. Sharply
declining home prices, high consumer debt, and the global economic slowdown
compounded Britain's economic problems, pushing the economy into recession in
the latter half of 2008 and prompting the then BROWN (Labour)
government to implement a number of measures to stimulate the economy and
stabilize the financial markets; these include nationalizing parts of the
banking system, temporarily cutting taxes, suspending public sector borrowing
rules, and moving forward public spending on capital projects. Facing
burgeoning public deficits and debt levels, in 2010 the CAMERON-led coalition
government (between Conservatives and Liberal Democrats) initiated a five-year
austerity program, which aims to lower London's budget deficit from over 10% of
GDP in 2010 to nearly 1% by 2015. In November 2011, Chancellor of the Exchequer
George OSBORNE announced additional austerity measures through 2017 because of
slower-than-expected economic growth and the impact of the euro-zone debt
crisis. The CAMERON government raised the value added tax from 17.5% to 20% in
2011. It has pledged to reduce the corporation tax rate to 23% by 2015. The
Bank of England (BoE) implemented an asset purchase
program of up to ?325 billion (approximately $525 billion) as of February 2011.
During times of economic crisis, the BoE coordinates
interest rate moves with the European Central Bank, but Britain remains outside
the European Economic and Monetary Union (EMU).
|
Source
: CIA |
Company name and address
GLOBEGEN LABORATORIES LIMITED
|
Company Name |
GLOBEGEN LABORATORIES LIMITED |
Company Number |
08033231 |
|
|
|
|
|
|
Registered
Address |
1406 COVENTRY ROAD |
Trading Address |
1406 Coventry Road |
|
|
YARDLEY |
|
|
|
|
BIRMINGHAM |
|
|
|
|
B25 8AE |
|
|
|
|
|
|
|
|
Website Address |
- |
|
|
|
Telephone Number
|
- |
Fax Number |
|
|
TPS |
- |
FPS |
No |
|
Incorporation
Date |
17/04/2012 |
Company Status |
Active - Newly Incorporated |
|
Previous Name |
GLOBGEN LABORATORIES LIMITED |
Type |
Private limited with Share Capital |
|
Date of Change |
17/04/2012 |
Filing Date of
Accounts |
- |
|
|
|
Share Capital |
- |
|
SIC03 |
|
Currency |
|
|
SIC03
Description |
|
||
|
SIC07 |
|
||
|
SIC07 Description
|
|
||
|
Principal
Activity |
Distribution of Pharmaceutical Products |
||
|
|
Commentary
|
No exact match CCJs are recorded against the
company. |
|
|
There has been no significant change in the company's credit limit. |
|
|
No recent changes in directorship are recorded. |
|
|
The company is not part of a group. |
|
|
Newer companies are proven to be more of an insolvency risk than more
established companies. |
|
Last 3 Years Credit Rating/Limit
|
No Last 3 Years Credit Rating/Limit Available. See Company Status |
Key Financials
|
No key Financials Registered |
Payment Information Summary
|
Days Beyond Terms |
Trend Indicator |
|
||||
|
Steady Improving Worsening |
|
CCJ
|
Total Number of
Exact CCJs - |
Total Value of
Exact CCJs - |
|
|
|
Total Number of
Possible CCJs - |
Total Value of
Possible CCJs - |
|
|
|
Total Number of
Satisfied CCJs - |
Total Value of
Satisfied CCJs - |
|
|
|
Total Number of
Writs - |
- |
|
|
Exact CCJ Details
There are no exact CCJ details
Possible CCJ Details
There are no possible CCJ details
Writ Details
There are no writ details
Mortgage Summary
|
Outstanding |
0 |
|
Satisfied |
0 |
|
Total Current Directors |
2 |
|
Total Current Secretaries |
0 |
|
Total Previous Directors / Company Secretaries |
0 |
|
Name |
Date
of Birth |
08/09/1952 |
|
|
Officers
Title |
Mr |
Nationality |
British |
|
Present
Appointments |
11 |
Function |
Director |
|
Appointment
Date |
17/04/2012 |
|
|
|
Address |
38 Meadow View, , Birmingham, B13 0AP |
||
|
|
|
|
|
|
Name |
Date
of Birth |
07/05/1984 |
|
|
Officers
Title |
Mr |
Nationality |
British |
|
Present
Appointments |
5 |
Function |
Director |
|
Appointment
Date |
17/04/2012 |
|
|
|
Address |
38 Meadow View, , Birmingham, B13 0AP |
||
|
|
|
|
|
Current Company Secretary
Top 20 Shareholders
Status History
|
No Status History found |
Event History
|
Date |
Description |
|
19/04/2012 |
New Board Member Mr A.M. Kanani
appointed |
|
19/04/2012 |
New Board Member Mr M.G. Kanani
appointed |
Previous Company Names
|
Date |
Previous Name |
|
17/04/2012 |
GLOBGEN LABORATORIES LIMITED |
|
Statistics
|
Summary
|
Group structure
No group structure
Statistics
|
Group |
|
|
Linkages |
0 companies |
|
Countries |
In 0 countries |
Exact CCJ Details
|
No CCJs found |
Possible CCJs Details
|
There are no possible CCJ details |
Writ Details
|
No writs found |
Mortgage Details
Creditor Details
|
No Creditor Data |
|
|
Total Value |
- |
|
Trade Debtors / Bad Debt Detail
|
No Debtor Data |
|
|
Total Value |
- |
|
Previous Director/Company Secretaries
|
No Previous Director Details |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.65 |
|
|
1 |
Rs.88.10 |
|
Euro |
1 |
Rs.69.83 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.